KINIKSA PHARMACEUTICALS LTD

CUSIP: G5269C101 Class: Foreign Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 158,230 Value ($000) $2,748 Avg Close Range
Q2 2023
Shares 325,542 Value ($000) $4,584 Avg Close Range
Q1 2023
Shares 806,825 Value ($000) $8,681 Avg Close Range
Q4 2022
Shares 147,939 Value ($000) $2,216 Avg Close Range
Q4 2021
Shares 69,723 Value ($000) $821 Avg Close Range
Q4 2020
Shares 78,352 Value ($000) $1,384 Avg Close Range
Q3 2020
Shares 148,303 Value ($000) $2,272 Avg Close Range